Study of a new pill for type 2 diabetes during Ramadan fasting
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an oral medication called orforglipron to see if it safely helps people with type 2 diabetes manage their blood sugar while they fast during Ramadan. You may be a good fit if you are planning to fast and your diabetes is not too severe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are planning to fast during Ramadan.
- Your blood sugar (A1C) is between 7.0% and 9.4% at a recent checkup.
- Your weight has stayed about the same (within 11 pounds) in the last 3 months.
- Your BMI is 25 or higher – this is a measure of body weight for height.
- You do not have a personal or family history of a rare thyroid cancer called medullary thyroid cancer or a condition called MEN2.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental daily pill (orforglipron) against an approved weekly injection (dulaglutide) in young people with type 2 diabetes. It aims to see which works better at controlling blood sugar and may offer a more convenient option.
This study tests how your body responds to a new diabetes pill, orforglipron, by looking at hormones and blood sugar. The results may help doctors choose the best treatment for people with type 2 diabetes.
This study looks at how people with type 2 diabetes experience fasting during Ramadan. By joining, you'll help researchers understand the challenges and benefits of fasting with diabetes.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
Hear when a new Glucose Metabolism Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.